share_log
Breakings ·  Jun 10 20:30
Surrozen Presents Preliminary Results From Phase 1a Study of Szn-043 in Healthy Volunteers and Patients With a History of Liver Cirrhosis at the 2024 European Association for the Study of the Liver (Easl) in Milan
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment